Literature DB >> 7527442

Outcome of Kupffer cell antigen presentation to a cloned murine Th1 lymphocyte depends on the inducibility of nitric oxide synthase by IFN-gamma.

C R Roland1, L Walp, R M Stack, M W Flye.   

Abstract

The interaction between lymphocytes and the resident hepatic macrophage, the Kupffer cell (KC), is relevant to the phenomenon of immune tolerance to Ags entering the liver. Tolerance to Ag administered via the portal vein can be prevented by the rare earth lanthanide metal, gadolinium (Gd). Therefore, we studied the ability of OVA-responsive, H-2d-restricted Th1 clones to proliferate in response to KCs from DBA/2J (H-2d) mice that had been injected with either saline (control) or a Gd solution. Whereas control KCs functioned as effective APCs, KCs from Gd-injected mice (GdKC) were incapable of sustaining the proliferative response of the Th1 clone to the 16 mer of OVA (323-339). This lack of proliferation was determined not to be caused by impaired Ag processing, but rather was the result of IFN-gamma-stimulated nitric oxide (NO) release by the APC: 1) In vitro addition of the nitric oxide synthase (NOS) inhibitor NG-methyl-L-arginine (NMMA) restored the ability of the Gd-treated KC to stimulate clone proliferation. 2) Additional of anti-IFN-gamma, but not anti-IL-2 or anti-IL-4, prevented the induction of NOS in the Gd-exposed KC and was associated with clone proliferation. 3) IFN-gamma levels from clone-GdKC-OVA cocultures closely paralleled the nitrite released by GdKCs. 4) Only the addition of rIFN-gamma, and not IL-2 or IL-4, to cultures of purified GdKCs resulted in the release of nitrite. The results of the study suggest an autocrine loop initiated by the interaction of the clone's TCR with the class II MHC molecule presenting processed OVA on the surface of KC. This interaction stimulates the Th1 lymphocyte to release IFN-gamma, which in turn induces NO release by KCs isolated from Gd-injected mice. This release of NO blocks Th1 proliferation. Such a feedback loop may have particular relevance to Ag-specific tolerance, which is not only induced by the administration of Ag into the portal vein, but is also prevented by Gd pretreatment of the recipient animal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527442

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Mechanisms of hepatic ischemia-reperfusion injury and protective effects of nitric oxide.

Authors:  Lian-Yue Guan; Pei-Yao Fu; Pei-Dong Li; Zhuo-Nan Li; Hong-Yu Liu; Min-Gang Xin; Wei Li
Journal:  World J Gastrointest Surg       Date:  2014-07-27

Review 2.  The liver works as a school to educate regulatory immune cells.

Authors:  Fenglei Li; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-22       Impact factor: 11.530

3.  Differential localization of allograft nitric oxide synthesis: comparison of liver and heart transplantation in the rat model.

Authors:  P C Kuo; E J Alfrey; N R Krieger; K Y Abe; P Huie; R K Sibley; D C Dafoe
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

4.  Hepatic stellate cells function as regulatory bystanders.

Authors:  Shintaro Ichikawa; Daniel Mucida; Aaron J Tyznik; Mitchell Kronenberg; Hilde Cheroutre
Journal:  J Immunol       Date:  2011-04-01       Impact factor: 5.422

Review 5.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

Review 6.  Hepatic gene transfer as a means of tolerance induction to transgene products.

Authors:  Paul A LoDuca; Brad E Hoffman; Roland W Herzog
Journal:  Curr Gene Ther       Date:  2009-04       Impact factor: 4.391

Review 7.  Role of nitric oxide in parasitic infections.

Authors:  S L James
Journal:  Microbiol Rev       Date:  1995-12

8.  Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.

Authors:  T S Dulkanchainun; J A Goss; D K Imagawa; G D Shaw; D M Anselmo; F Kaldas; T Wang; D Zhao; A A Busuttil; H Kato; N G Murray; J W Kupiec-Weglinski; R W Busuttil
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

Review 9.  Liver architecture, cell function, and disease.

Authors:  Hiromi Ishibashi; Minoru Nakamura; Atsumasa Komori; Kiyoshi Migita; Shinji Shimoda
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

Review 10.  The Liver-Immunity Nexus and Cancer Immunotherapy.

Authors:  James C Lee; Michael D Green; Laura A Huppert; Christine Chow; Robert H Pierce; Adil I Daud
Journal:  Clin Cancer Res       Date:  2021-07-20       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.